# US 2004/0083004 A1 · Use of snap-on semiannular augments to inhibit multi-directional instability after total hip arthroplasty

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0083004 A1
- Document ID: US20040083004A1
- Status: Published application
- Kind: A1
- Application number: 10/612,784
- Filed: 2003-07-02
- Published: 2004-04-29
- Earliest claimed: 2002-10-23
- Inventors: Ray C. Wasielewski
- Web page: https://patentgrep.com/patent/US20040083004A1

## CPC

- A61F 2/30721: {Accessories}
- A61F 2/32: for the hip
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/24: Collagen
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/3629: {Intestinal tissue, e.g. small intestinal submucosa}
- A61L 27/3633: {Extracellular matrix [ECM]}
- A61L 27/3645: {Connective tissue}
- A61F 2/34: Acetabular cups
- A61F 2002/2817: {Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]}
- A61F 2002/30032: {differing in absorbability or resorbability, i.e. in absorption or resorption time}
- A61F 2002/30062: {(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive}
- A61F 2002/30331: {made by longitudinally pushing a protrusion into a complementarily-shaped recess, e.g. held by friction fit}
- A61F 2002/30433: {using additional screws, bolts, dowels, rivets or washers e.g. connecting screws}
- A61F 2002/30448: {using adhesives}
- A61F 2002/305: {Snap connection}
- A61F 2002/30604: {modular}
- A61F 2002/30787: {inclined obliquely with respect to each other}
- A61F 2002/30808: {parallel}
- A61F 2002/3233: {having anti-luxation means for preventing complete dislocation of the femoral head from the acetabular cup}
- A61F 2002/3401: {with radial apertures, e.g. radial bores for receiving fixation screws}
- A61F 2002/3443: {with an anti-luxation elevated rim portion, e.g. on the inner shell}
- A61F 2002/3611: {Heads or epiphyseal parts of femur}
- A61F 2210/0004: bioabsorbable
- A61F 2220/0025: Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F 2220/0033: made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
- A61F 2220/0041: using additional screws, bolts, dowels or rivets, e.g. connecting screws
- A61F 2220/005: using adhesives
- A61F 2250/0031: made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts
- A61F 2310/00365: Proteins; Polypeptides; Degradation products thereof
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Particular embodiments of the present invention make use of semiannular stabilizing augments adapted to be mounted about the acetabular cup assembly of the prosthetic hip joint to provide constraint for the joint and to concurrently provide a range of motion desired by patients after surgery, but with the additional benefit of doing so without substantially increasing the risks of dislocation. At least one exemplary embodiment utilizes a semiannular augment formed from biologically reabsorbable material to temporarily constrain the prosthetic ball within the prosthetic acetabular cup. In such an embodiment, it is desired that the biologically reabsorbable material degrades in general proportion to the level of tissue developed by the patient's own body to supplement constraint of the hip joint. Thus, the artificial constraining augments may degrade inversely proportional to the patient's need for inhibition.

## Claims

### Claim 1

A prosthetic device for use with a hip replacement prosthesis that includes an acetabular cup assembly adapted to be fastened to a patient's pelvis and a femoral stem adapted to be fastened to the patient's femur, where the femoral stem includes a ball component at its proximal end received within the acetabular cup assembly to form a ball joint type coupling, the constraining device comprising:
a semiannular augment adapted to be mounted approximate to a rim of an acetabular cup assembly of a hip replacement prosthesis, wherein the augment assists in improving stability, at least temporarily, of a ball joint type coupling between the acetabular cup assembly and a femoral stem of the hip replacement prosthesis;
the semiannular augment being formed from an augment material selected from the group consisting of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials.

### Claim 2 (depends on 1)

The prosthetic device of claim 1, further comprising at least one fastener for mounting the semiannular augment to the acetabular cup assembly, the fastener being formed from a fastener material selected from the group consisting of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials.

### Claim 3 (depends on 2)

The prosthetic device of claim 2, wherein the fastener material includes at least one, or an equivalent, of:
a poly-L-lactic acid material; and
collagen.

### Claim 4 (depends on 2)

The prosthetic device of claim 2, wherein the fastener comprises at least one of:
a screw;
a snap;
a clip;
a keyway;
a dowel; and
a rivet.

### Claim 5 (depends on 1)

The prosthetic device of claim 1, wherein the augment material includes at least one, or an equivalent, of:
extra cellular matrices (ECMs);
poliglecaprone 25;
polydioxanone;
surgical gut suture (SGS);
gut;
polyglactin 910;
human autograft tendon material;
collagen fiber;
poly-L-lactic acid (PLLA);
polylactic acid (PLA);
polylactides (Pla);
racemic form of polylactide (D,L-Pla);
poly(L-lactide-co-D,L-lactide);
polyglycolides (PGa);
polyglycolic acid (PGA);
polycaprolactone (PCL);
polydioxanone (PDS);
polyhydroxyacids; and
resorbable plate material.

### Claim 6 (depends on 5)

The prosthetic device of claim 5, wherein the extra cellular matrices (ECMs) include at least one of:
porcine small intestine submucosa (SIS);
xenogeneic small intestine submucosa (xSIS);
urinary bladder submucosa (UBS);
laminated intestinal submucosa; and
glutaraldehyde-treated bovine pericardium (GLBP).

### Claim 7 (depends on 1)

The prosthetic device of claim 1, wherein a distal surface of the semiannular augment opposing a surface of the semiannular augment abutting the rim of the acetabular cup assembly is contoured to approximate the shape of a portion of the neck of the femoral component potentially coming into contact therewith.

### Claim 8 (depends on 1)

The prosthetic device of claim 1, wherein the semiannular augment is positioned on an anterior/superior portion of the rim of the acetabular cup assembly.

### Claim 9 (depends on 1)

The prosthetic device of claim 1, wherein:
the femoral component includes a ball at its proximal end for mating with the acetabular cup assembly to form a ball-joint coupling; and
the semiannular augment includes a contoured, radially inner surface to approximate an outer surface of the ball of the femoral component potentially coming into contact therewith.

### Claim 10 (depends on 9)

The prosthetic device of claim 9, wherein the contoured, radially inner surface of the augment is substantially semi-spherically shaped.

### Claim 11 (depends on 9)

The prosthetic device of claim 9, wherein the contoured, radially inner surface is substantially arcuate.

### Claim 12 (depends on 1)

The prosthetic device of claim 1, wherein the semiannular augment is mounted to a proximal rim surface of the acetabular cup assembly.

### Claim 13 (depends on 1)

The prosthetic device of claim 1, wherein the semiannular augment is mounted to a proximal rim surface of a cup-shaped bearing insert component of the acetabular cup assembly.

### Claim 14 (depends on 2)

The prosthetic device of claim 2, wherein the semiannular augment includes at least one integrated fastener.

### Claim 15 (depends on 14)

The prosthetic device of claim 14, wherein the integrated fastener includes a snap-on retention member enabling snap-on-type mounting of the semiannular augment to the acetabular cup assembly.

### Claim 16 (depends on 1)

The prosthetic device of claim 1, wherein the augment material is supplemented with an agent to promote the formation of scar tissue.

### Claim 17 (depends on 1)

The prosthetic device of claim 1, wherein the augment material is supplemented with a clotting agent.

### Claim 18 (depends on 1)

The prosthetic device of claim 1, wherein the augment material is supplemented with an antibacterial agent.

### Claim 19 (depends on 1)

The prosthetic device of claim 1, wherein the augment material is adapted to be substantially absorbed by a patient's body after implantation and to be substantially replaced by scar tissue.

### Claim 20 (depends on 19)

The prosthetic device of claim 19, wherein the augment material is adapted to be substantially absorbed and replaced by scar tissue within approximately 6 months after implantation.

### Claim 21 (depends on 1)

The prosthetic device of claim 1, wherein the semiannular augment extends less than 360 degrees about the femoral stem.

### Claim 22 (depends on 1)

The prosthetic device of claim 1, wherein the semiannular augment extends 180 degrees or less about the femoral stem.

### Claim 23 (depends on 1)

The prosthetic device of claim 1, wherein the semiannular augment extends 90 degrees or less about the femoral stem.

### Claim 24 (depends on 1)

The prosthetic device of claim 1, wherein the semiannular augment extends 45 degrees or less about the femoral stem.

### Claim 25 (depends on 1)

The prosthetic device of claim 1, wherein:
the femoral component includes a ball at its proximal end for mating with the acetabular cup assembly to form a ball-joint connection; and
the semiannular augment assists in constraining the ball within the acetabular cup assembly.

### Claim 26 (depends on 1)

The prosthetic device of claim 1, wherein:
the femoral component includes a ball at its proximal end for mating with the acetabular cup assembly to form a ball-joint connection; and
the semiannular augment assists in restraining the ball within the acetabular cup assembly.

### Claim 27

A hip prosthesis comprising:
an acetabular cup assembly adapted to be fastened to a patient's pelvis;
a femoral stem adapted to be fastened to the patient's femur, the femoral stem including a ball component at its proximal end received within the acetabular cup assembly to form a ball joint type coupling; and
a semiannular augment mounted to a distal end of the acetabular cup assembly, adjacent to the ball component, wherein the semiannular augment assists in stabilizing the ball joint type coupling between the acetabular cup assembly and the femoral stem;
the semiannular augment being formed from an augment material selected from the group consisting of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials.

### Claim 28 (depends on 27)

The hip prosthesis of claim 27, further comprising at least one fastener mounting the semiannular augment to a distal rim surface of the acetabular cup assembly, wherein the fastener is formed from a fastener material selected from the group consisting of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials.

### Claim 29 (depends on 28)

The hip prosthesis of claim 28, wherein the fastener material includes at least one, or an equivalent, of:
a poly-L-lactic acid material; and
collagen.

### Claim 30 (depends on 28)

The hip prosthesis of claim 28, wherein the fastener comprises at least one of:
a screw;
a snap;
a clip;
a keyway;
a dowel; and
a rivet.

### Claim 31 (depends on 27)

The hip prosthesis of claim 27, wherein the augment material includes at least one, or an equivalent, of:
extra cellular matrices (ECMs);
poliglecaprone 25;
polydioxanone;
surgical gut suture (SGS);
gut;
polyglactin 910;
human autograft tendon material;
collagen fiber;
poly-L-lactic acid (PLLA);
polylactic acid (PLA);
polylactides (Pla);
racemic form of polylactide (D,L-Pla);
poly(L-lactide-co-D,L-lactide);
polyglycolides (PGa);
polyglycolic acid (PGA);
polycaprolactone (PCL);
polydioxanone (PDS);
polyhydroxyacids; and
resorbable plate material.

### Claim 32 (depends on 31)

The hip prosthesis of claim 31, wherein the extra cellular matrices (ECMs) include at least one of:
porcine small intestine submucosa (SIS);
xenogeneic small intestine submucosa (xSIS);
urinary bladder submucosa (UBS);
laminated intestinal submucosa; and
glutaraldehyde-treated bovine pericardium (GLBP).

### Claim 33 (depends on 27)

The hip prosthesis of claim 27, wherein a distal surface of the semiannular augment is contoured to approximate the shape of a portion of the neck of the femoral component.

### Claim 34 (depends on 27)

The hip prosthesis of claim 27, wherein the semiannular augment is positioned on the anterior/superior portion of the acetabular cup assembly.

### Claim 35 (depends on 27)

The hip prosthesis of claim 27, wherein the semiannular augment includes a contoured, radially inner surface to approximate an outer surface of the ball of the femoral stem.

### Claim 36 (depends on 27)

The hip prosthesis of claim 27, wherein the contoured, radially inner surface of the semiannular augment is substantially semi-spherically shaped.

### Claim 37 (depends on 27)

The hip prosthesis of claim 27, wherein the augment material is supplemented with an agent to promote the formation of scar tissue.

### Claim 38 (depends on 27)

The hip prosthesis of claim 27, wherein the augment material is supplemented with a clotting agent.

### Claim 39 (depends on 27)

The hip prosthesis of claim 27, wherein the augment material is supplemented with an antibacterial agent.

### Claim 40 (depends on 27)

The hip prosthesis of claim 27, wherein the augment material is adapted to be substantially absorbed by a patient's body after implantation and to be substantially replaced by scar tissue.

### Claim 41 (depends on 40)

The hip prosthesis of claim 40, wherein the augment material is adapted to be substantially absorbed and replaced by scar tissue within approximately 6 months after implantation.

### Claim 42 (depends on 27)

The hip prosthesis of claim 27, wherein the semiannular augment extends less than 360 degrees about the femoral stem.

### Claim 43 (depends on 27)

The hip prosthesis of claim 27, wherein the semiannular augment extends 180 degrees or less about the femoral stem.

### Claim 44 (depends on 27)

The hip prosthesis of claim 27, wherein the semiannular augment extends 90 degrees or less about the femoral stem.

### Claim 45 (depends on 27)

The hip prosthesis of claim 27, wherein the semiannular augment extends 45 degrees or less about the femoral stem.

### Claim 46 (depends on 27)

The hip prosthesis of claim 27, wherein the semiannular augment assists in constraining the ball within the acetabular cup assembly.

### Claim 47 (depends on 27)

The hip prosthesis of claim 27, wherein the semiannular augment assists in restraining the ball within the acetabular cup assembly.

### Claim 48 (depends on 27)

The hip prosthesis of claim 27, comprising a plurality of the semiannular augments mounted to the distal end of the acetabular cup assembly, adjacent to the ball component.

### Claim 49 (depends on 48)

The hip prosthesis of claim 48, wherein a first one of the semiannular augment restrains the ball within the acetabular cup assembly and a second one of the semiannular augments is adapted to abut the femoral stem when the femoral stem pivots to a predetermined angle.

### Claim 50 (depends on 49)

The hip prosthesis of claim 49, wherein the second semiannular augment is diametrically opposed to the first semiannular augment about the acetabular cup assembly.

### Claim 51 (depends on 27)

The hip prosthesis of claim 27, wherein the acetabular cup assembly includes a cup-shaped bearing insert receiving the ball component of the femoral stem and the semiannular augment is mounted to a rim of the bearing insert.

### Claim 52 (depends on 51)

The hip prosthesis of claim 51, wherein a first one of the semiannular augment restrains the ball within the acetabular cup assembly and a second one of the semiannular augments is adapted to abut the femoral stem when the femoral stem pivots to a predetermined angle.

### Claim 53 (depends on 52)

The hip prosthesis of claim 52, wherein the second semiannular augment is diametrically opposed to the first semiannular augment about the acetabular cup assembly.

### Claim 54

A prosthetic constraining kit for implantation in proximity to a hip joint, comprising a plurality of constraining augments being adapted to be individually fastened on at least one of an acetabular prosthesis and about an acetabular cavity within a hip bone and circumferentially positionable about a femoral member taken from a group consisting of a femur and a femoral prosthesis, where the constraining augments at least partially define a central aperture allowing the femoral member to extend therethrough and allowing a range of angular motion of the femoral member while inhibiting a femoral head of the femoral member from completely passing distally through the central aperture.

### Claim 55 (depends on 54)

The prosthetic constraining kit of claims 54, wherein the constraining augments comprise at least one of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials.

### Claim 56 (depends on 54)

The prosthetic constraining kit of claim 54, wherein the constraining augments are circumferentially positioned to define a ring.

### Claim 57 (depends on 54)

The prosthetic constraining kit of claim 54, wherein at least two of the augments are spaced apart to define a discontinuous ring.

### Claim 58 (depends on 57)

The prosthetic constraining kit of claim 57, wherein the discontinuous ring includes more than one discontinuity.

### Claim 59 (depends on 54)

The prosthetic constraining kit of claim 54, wherein each constraining augment includes at least one fastener for mounting the augment to the distal rim surface of the acetabular cup assembly, wherein the fastener is formed from a fastener material selected from the group consisting of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials.

### Claim 60 (depends on 59)

The prosthetic constraining kit of claim 59, wherein the fastener material includes at least one, or an equivalent, of:
a poly-L-lactic acid material; and
collagen.

### Claim 61 (depends on 59)

The prosthetic constraining kit of claim 59, wherein the fastener comprises at least one of:
a screw;
a snap;
a clip;
a keyway;
a dowel; and
a rivet.

### Claim 62 (depends on 55)

The prosthetic constraining kit of claim 55, wherein the material of the constraining augments includes at least one, or an equivalent, of:
extra cellular matrices (ECMs);
poliglecaprone 25;
polydioxanone;
surgical gut suture (SGS);
gut;
polyglactin 910;
human autograft tendon material;
collagen fiber;
poly-L-lactic acid (PLLA);
polylactic acid (PLA);
polylactides (Pla);
racemic form of polylactide (D,L-Pla);
poly(L-lactide-co-D,L-lactide);
polyglycolides (PGa);
polyglycolic acid (PGA);
polycaprolactone (PCL);
polydioxanone (PDS);
polyhydroxyacids; and
resorbable plate material.

### Claim 63 (depends on 62)

The prosthetic constraining kit of claim 62, wherein the extra cellular matrices (ECMs) include at least one of:
porcine small intestine submucosa (SIS);
xenogeneic small intestine submucosa (xSIS);
urinary bladder submucosa (UBS);
laminated intestinal submucosa; and
glutaraldehyde-treated bovine pericardium (GLBP).

### Claim 64 (depends on 54)

The prosthetic constraining kit of claim 54, wherein a distal surface of at least one constraining augment is contoured to approximate the shape of a portion of the neck of the femoral member.

### Claim 65 (depends on 54)

The prosthetic constraining kit of claim 54, wherein at least one constraining augment is positioned on the anterior/superior portion of the acetabular cup assembly.

### Claim 66 (depends on 54)

The prosthetic constraining kit of claim 54, wherein at least one of the constraining augments has an inner radial surface that is substantially semi-spherically shaped to complement the shape of the femoral head of the femoral member.

### Claim 67 (depends on 59)

The prosthetic constraining kit of claim 59, wherein the at least one fastener is an integrated fastener including snap-on retention members enabling snap-on mounting to the acetabular cup assembly.

### Claim 68 (depends on 55)

The prosthetic constraining kit of claim 55, wherein the material of at least one of the constraining augments is supplemented with an agent to promote the formation of scar tissue.

### Claim 69 (depends on 55)

The prosthetic constraining kit of claim 55, wherein the material of at least one of the constraining augments is supplemented with a clotting agent.

### Claim 70 (depends on 55)

The prosthetic constraining kit of claim 55, wherein the material of at least one of the constraining augments is supplemented with an antibacterial agent.

### Claim 71 (depends on 54)

The prosthetic constraining kit of claim 54, wherein a distal surface of at least one of the constraining augments further includes an elevated portion for reducing angular movement of the femoral member in the radial direction of the elevated portion.

### Claim 72 (depends on 71)

The prosthetic constraining kit of claim 71, wherein the elevated portion is located in a radially outer region of the constraining augment when mounted to one of the acetabular prosthesis and an area surrounding the acetabular cavity within the hip bone.

### Claim 73

A constraining device for, at least temporarily, promoting engagement of a prosthetic femoral stem component with a prosthetic acetabular component of a prosthetic hip assembly, the constraining device comprising a semiannular segment of material selected from the group consisting of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials.

### Claim 74 (depends on 73)

The constraining device of claim 73, wherein the semiannular segment of material includes at least one, or an equivalent, of:
extra cellular matrices (ECMs);
poliglecaprone 25;
polydioxanone;
surgical gut suture (SGS);
gut;
polyglactin 910;
human autograft tendon material;
collagen fiber;
poly-L-lactic acid (PLLA);
polylactic acid (PLA);
polylactides (Pla);
racemic form of polylactide (D,L-Pla);
poly(L-lactide-co-D,L-lactide);
polyglycolides (PGa);
polyglycolic acid (PGA);
polycaprolactone (PCL);
polydioxanone (PDS);
polyhydroxyacids; and
resorbable plate material.

### Claim 75 (depends on 74)

The constraining device of claim 74, wherein the extra cellular matrices (ECMs) includes at least one of:
porcine small intestine submucosa (SIS);
xenogeneic small intestine submucosa (xSIS);
urinary bladder submucosa (UBS);
laminated intestinal submucosa; and
glutaraldehyde-treated bovine pericardium (GLBP).

### Claim 76 (depends on 73)

The constraining device of claim 73, wherein the semiannular segment of material is molded in the form of a constraining ring adapted to be segmented and mounted to a rim of an acetabular cup assembly of the acetabular prosthesis component.

### Claim 77 (depends on 73)

The constraining device of claim 73, wherein the semiannular segment of material is adapted to be substantially absorbed by a patient's body after implantation and to be substantially replaced by scar tissue.

### Claim 78 (depends on 77)

The constraining device of claim 77, wherein the semiannular segment of material is adapted to be substantially absorbed and replaced by scar tissue within approximately 6 months after implantation.

### Claim 79 (depends on 73)

The constraining device of claim 73, wherein the semiannular segment of material is supplemented with an agent to promote the formation of scar tissue.

### Claim 80 (depends on 73)

The constraining device of claim 73, wherein the semiannular segment of material is supplemented with a clotting agent.

### Claim 81 (depends on 73)

The constraining device of claim 73, wherein the semiannular segment of material is supplemented with an antibacterial agent.

### Claim 82

A restraining device for, at least temporarily, promoting engagement between at least two of a first prosthetic joint component, a second prosthetic joint component, a first bone component, and a second bone component, wherein the restraining device is comprised of a restraining material including at least one of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials, wherein the restraining device does not circumscribe at least one of the first prosthetic joint component, the second prosthetic joint component, the first bone component, and the second bone component.

### Claim 83 (depends on 82)

The restraining device of claim 82, wherein the restraining material includes at least one, or an equivalent, of:
extra cellular matrices (ECMs);
poliglecaprone 25;
polydioxanone;
surgical gut suture (SGS);
gut;
polyglactin 910;
human autograft tendon material;
collagen fiber;
poly-L-lactic acid (PLLA);
polylactic acid (PLA);
polylactides (Pla);
racemic form of polylactide (D,L-Pla);
poly(L-lactide-co-D,L-lactide);
polyglycolides (PGa);
polyglycolic acid (PGA);
polycaprolactone (PCL);
polydioxanone (PDS);
polyhydroxyacids; and
resorbable plate material.

### Claim 84 (depends on 83)

The restraining device of claim 83, wherein the extra cellular matrices (ECMs) includes at least one of:
porcine small intestine submucosa (SIS);
xenogeneic small intestine submucosa (xSIS);
urinary bladder submucosa (UBS);
laminated intestinal submucosa; and
glutaraldehyde-treated bovine pericardium (GLBP).

### Claim 85 (depends on 82)

The restraining device of claim 82, wherein the restraining device is adapted to be mounted to at least one of the first prosthetic joint component, the second prosthetic joint component, the first bone component, and the second bone component.

### Claim 86 (depends on 82)

The restraining device of claim 82, wherein the restraining device is adapted to be substantially absorbed by a patient's body after implantation and to be substantially replaced by scar tissue.

### Claim 87 (depends on 82)

The restraining device of claim 82, wherein the restraining material is adapted to be substantially absorbed and replaced by scar tissue within approximately 6 months after implantation.

### Claim 88 (depends on 82)

The restraining device of claim 82, wherein the restraining material is supplemented with an agent to promote the formation of scar tissue.

### Claim 89 (depends on 82)

The restraining device of claim 82, wherein the restraining material is supplemented with a clotting agent.

### Claim 90 (depends on 82)

The restraining device of claim 82, wherein the restraining material is supplemented with an antibacterial agent.

### Claim 91

A method for providing at least temporary stability to a prosthetic hip joint that includes an acetabular cup assembly bonded to a patient's pelvis and a femoral stem bonded to the patient's femur, where the femoral stem includes a ball component at its proximal end received within the acetabular cup assembly to form a ball joint coupling, the method comprising the step of:
mounting a stability enhancement augment to the prosthetic hip joint to improve, at least temporarily, the stability of the prosthetic hip joint, wherein the stability enhancement augment is formed from an augment material selected from the group consisting of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials.

### Claim 92 (depends on 91)

The method of claim 91, wherein:
the stability enhancement augment maximally exhibits a semiannular shape covering less than 360 degrees and partially defines an aperture; and
the mounting step includes the step of mounting the stability enhancement augment about a rim of the acetabular cup assembly where the femoral stem passes through the aperture.

### Claim 93 (depends on 91)

The method of claim 91, wherein the mounting step includes the step of fastening the stability enhancement augment to the rim of the acetabular cup assembly with at least one fastener formed from a fastener material comprising at least one of a biologic material, a biologically absorbable material, and a combination of biologic and biologically absorbable materials.

### Claim 94 (depends on 93)

The method of claim 93, wherein the fastener comprises at least one of:
a screw;
a snap;
a clip;
a keyway;
a dowel; and
a rivet.

### Claim 95 (depends on 91)

The method of claim 91, wherein the augment material is loaded with at least one of an agent to promote formation of scar tissue, a clotting agent, and an antibacterial agent.

### Claim 96 (depends on 91)

The method of claim 91, wherein the augment material is adapted to be substantially absorbed by a patient's body after the mounting step and to be substantially replaced by scar tissue.

### Claim 97 (depends on 91)

The method of claim 91, wherein the stability enhancement augment is in the form of a paste material and the mounting step includes the step of applying the paste material to at least a portion of the patient's prosthetic hip joint.

### Claim 98 (depends on 97)

The method of claim 97, wherein the augment material is loaded with at least one of an agent to promote formation of scar tissue, a clotting agent, and an antibacterial agent.

### Claim 99 (depends on 98)

The method of claim 98, wherein the augment material is adapted to be substantially absorbed by a patient's body after the mounting step and to be substantially replaced by scar tissue.

### Claim 100 (depends on 99)

The method of claim 99, wherein the augment material is adapted to be substantially absorbed and replaced by scar tissue within approximately 6 months after implantation.

### Claim 101

A method for providing at least temporary stability to a prosthetic hip joint which includes an acetabular cup assembly bonded to a patient's pelvis and a femoral stem bonded to the patient's femur, where the femoral stem includes a ball component at its proximal end received within the acetabular cup assembly to form a ball joint type coupling, the method comprising the step of:
mounting a plurality of individual constraining augments on an acetabular prosthesis, where the individual constraining augments at least partially define a central aperture for allowing a femoral component to extend therethrough while inhibiting a femoral head of the femoral component from completely passing distally through the central aperture.

### Claim 102 (depends on 101)

The method of claim 101, wherein the mounting step includes selectively manipulating the contour of the constraining augments to customize the shape of the augments.

### Claim 103 (depends on 101)

The method of claim 101, wherein the mounting step includes the step of selectively positioning the constraining augments circumferentially about the acetabular prosthesis.

### Claim 104 (depends on 101)

The method of claim 101, wherein the mounting step includes excavating the acetabular prosthesis.

### Claim 105 (depends on 101)

The method of claim 101, wherein the mounting step includes excavating the constraining augments.

### Claim 106 (depends on 101)

The method of claim 101, wherein the mounting step includes inserting at least one of a fastener coupled to the acetabular prosthesis, a fastener independent of the acetabular prosthesis, and a glue into a cavity within the acetabular prosthesis.

### Claim 107 (depends on 101)

The method of claim 101, wherein the constraining augments are adapted to be substantially absorbed by a patient's body after implantation and to be substantially replaced by scar tissue.

### Claim 108 (depends on 86)

The method of claim 86, wherein the constraining augments are adapted to be substantially absorbed and replaced by scar tissue within approximately 6 months after implantation.
